机构:[1]Capital Medical University School of Traditional Chinese Medicine, Beijing Key of TCM Collateral DiseaseTheory Research, Beijing 100069, China[2]Central Laboratory, XuanWu Hospital, CapitalMedical University, Beijing GeriatricMedical Research Center, Beijing 100053,China首都医科大学宣武医院中心实验室[3]Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
Wuzhuyu decoction (WZYD) has been clinically used to treat migraine effectively since Eastern Han Dynasty of ancient China. However, its antimigrainic ingredients remain unclear. In present study, the antimigrainic ingredients of WZYD were explored and optimized in nitroglycerin-induced migraine rats through correlation analysis of decoction spectra-pharmacological effects and absorption spectra-pharmacological using entropy-weighted partial least squares regression method. The decoction spectra and absorption spectra were obtained through the determination of nine main ingredients in ten kinds of WZYDs and WZYDs' single-pass intestinal perfusion samples using high performance liquid chromatography-diode array detector. The pharmacodynamics indexes related to migraine model rats were detected using high performance liquid chromatography method and kits after oral administration of WZYDs. Then, the key ingredients influencing indexes were achieved through the correlation analysis. And the optimization of key ingredients was acquired through uniform design experiment. The pharmacodynamic verification test was used to clarify the advantages of the optimized sample. The results showed that the final optimized sample, in which the concentrations of rutaecarpine, evodiamine, ginsendside Rb-1, 6-gingerol, ginsendside Rg(1), rutaevine, and limonin were 0.081, 0.565, 1.455, 0.159, 0.871, 0.178, and 0.009mgmL(-1), respectively, provided the best comprehensive effect than another optimized sample and the best uniform design sample. Therefore, a new reliable method for rapidly recognizing and optimizing the effective constituents of WZYD treating migraine was established.
基金:
National Natural Sciences Foundation of China [81473360, 81773860]; National Special Project for "Research and Development of New Drugs" [2017ZX09201009-001]; Beijing Natural Science Foundation [7174281]
第一作者机构:[1]Capital Medical University School of Traditional Chinese Medicine, Beijing Key of TCM Collateral DiseaseTheory Research, Beijing 100069, China
通讯作者:
通讯机构:[1]Capital Medical University School of Traditional Chinese Medicine, Beijing Key of TCM Collateral DiseaseTheory Research, Beijing 100069, China
推荐引用方式(GB/T 7714):
Yongsong Xu,Sha Wu,Yanchuan Wu,et al.Recognition and Optimization of Ingredients Treating Nitroglycerin-Induced Migraine Rats from Wuzhuyu Decoction[J].EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE.2019,2019:doi:10.1155/2019/6156754.
APA:
Yongsong Xu,Sha Wu,Yanchuan Wu,Muxin Gong&Zhimin Wang.(2019).Recognition and Optimization of Ingredients Treating Nitroglycerin-Induced Migraine Rats from Wuzhuyu Decoction.EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2019,
MLA:
Yongsong Xu,et al."Recognition and Optimization of Ingredients Treating Nitroglycerin-Induced Migraine Rats from Wuzhuyu Decoction".EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2019.(2019)